New figures show melanoma most common cancer in young Queenslanders
8 January 2016
Around 110 melanomas are diagnosed in males aged under 35 each year, followed by 80 cases of testicular cancer, while around 140 new cases of melanoma are diagnosed in Queensland females under 35. Thyroid cancer is the second most common cancer in this group affecting more than 60 women each year.
Commenting on the statistics MIA’s Research Director Professor Graham Mann highlighted that sun and solarium exposure are the most common causes of melanoma in younger people.
“We must remember that melanoma rates are influenced by UV radiation exposure that has happened many years earlier, especially in the formative years. The variances we are seeing may be because of the way men and women have used sunbaking and solariums differently.
“Many teenage girls and young women deliberately sunbake and may not cover up with a hat or protective clothing, so maybe this is having an impact. Or possibly male-female biology may be a factor. But man or woman, pursuing that summer glow is a gamble and ultimately can cost you a lot more than it’s worth,” Professor Mann said.
The latest Queensland figures are based on 2012 data prior to the banning of sun beds.
“Fortunately commercial solariums have been banned since about 2014. This was partly because we’ve learned that, among people who used solariums, most of their melanomas before the age of 30 were due to sunbed use. Women were about twice as likely to use sunbeds as men were, and maybe that is also contributing to the different rates we are seeing,” Professor Mann added.
Queensland has the highest rates of skin cancer in the world. Around 3,000 melanoma and 133,000 non-melanoma skin cancers are diagnosed across the state each year.
You can read more on this story here.
Join us at the 2nd Melanoma Patients Australia webinar 'Psychological Health & Wellbeing'.
You're invited to be a C2S charity superstar, and together we can run over melanoma!
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.